Drug details

Tofidence (tocilizumab-bavi injection)

type of Immunosuppressants

Tofidence (tocilizumab-bavi) is an interleukin-6 (IL-6) receptor antagonist indicated for treatment of adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs); patients 2 years of age and older with active polyarticular juvenile

This drug may have the following side effects:

• rash,
• dizziness,
• headache,
• abdominal pain,
• runny or stuffy nose,
• gastritis, and
• high blood pressure (hypertension),
• bronchitis,
• increased ALT,
• upper respiratory tract infections,
• mouth ulcers,
• increased transaminase.

The following drugs are related to Tofidence, either as a replacement or used together:

• Otezla (apremilast tablets)
• Arava (leflunomide)
• Azulfidine EN-Tabs (sulfasalazine delayed release tablets)
• Cimzia (certolizumab pegol injection)
• Cosentyx (secukinumab injection)
• Enbrel (etanercept)
• Simponi Aria (golimumab for infusion)
• Plaquenil (hydroxychloroquine)
• Trexall (methotrexate)
• Rheumatrex (methotrexate tablets)
• Skyrizi (risankizumab-rzaa injection)